Clinical Trial Update: Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating bortezomib with pemetrexed disodium in advanced non-small cell lung cancer and other solid tumors; completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumor

Drugs mentioned

• Bortezomib (bortezomib)
• Pemetrexed disodium (Pemetrexed disodium)

Snippet

Sponsor: University of California, Davis | Conditions: Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-06-23